Trial NCT04426695
Publication Somersan-Karakaya S
Primary outcome on the report: 1) Primary virologic efficacy endpoint - time-weighted average (TWA) daily change from baseline (day 1) viral load in nasopharyngeal samples through day 7; 2) Primary clinical efficacy endpoint - proportion of patients who died or required mechanical ventilation from day 6-29 and day 1-29.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.